陈小勇;赵建宁;包倪荣;王与荣;

• 1:南京大学医学院临床学院南京军区南京总医院骨科

摘要(Abstract)：

<正>人工关节置换术是治疗终末期骨关节疾病和老年股骨颈骨折最有效的方法之一,已应用于临床半个多世纪,它可以显著地提高患者的生存质量。尽管该治疗手段疗效确切,但术后远期的主要并发症——骨溶解和无菌性松动,已成为人

关键词(KeyWords)： 人工关节;无菌性松动;标志物;药物防治

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金资助项目(编号:81000814)

作者(Author): 陈小勇;赵建宁;包倪荣;王与荣;

Email:

DOI:

参考文献(References)：

• [1]Hooper GJ,Rothwell AG,Stringer M,et al.Revision following cemen-ted and uncemented primary total hip replacement:a seven-year anal-ysis from the New Zealand Joint Registry[J].J Bone Joint Surg Br,2009,91:451-458.
• [2]Landgraeber S,L er F,Heep H,et al.Tartrate-resistant acid phos-phatase 5b and C-terminal telopeptides of type I collagen as markersfor diagnosis of aseptic loosening after total hip replacement[J].ArchOrthop Trauma Surg,2010,130:441-445.
• [3]Hundri-Haspl Z,Pecina M,Haspl M,et al.Plasma cytekines asmarkers of aseptic prosthesis loosening[J].Clin Orthop,2006,453:299-304.
• [4]Beraudi A,Stea S,Cremonini S,et al.Assessment of five interleukinsin human synovial fluid as possible markers for aseptic loosening of hiparthroplasty[J].Artif Organs,2009,33:538-543.
• [5]Shanbhag AS,Kaufman AM,Hayata K,et al.Assessing osteolysis withuse of high-throughput protein ehips[J].J Bone Joint Surg Am,2007,89:1081-1089.
• [6]朱亮亮,赵建宁.人工关节无菌性松动的分子机制及药物干预[J].医学研究生学报,2009,6:320-323.
• [7]Granchi D,Pellacani A,Spina M,et al.Serum levels of osteoprotegerinand receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis[J].J Bone Joint Surg Am,2006,88:1501-1509.
• [8]Li MG,Thorsen K,Nilsson KG.Increased bone turnover as reflected bybiochemical markets in patients with potentially unstable fixation of thetibial component[J].Arch Orthop Trauma Surg,2004,124:404-409.
• [9]Savarino L,Granchi D,Cenni E.Systemic cross-linked N-terminaftelopeptide and procollagen I C-terminal extension peptide as markersof bone turnover after total hip arthroplasty[J].J Bone Joint Surg Br,2005,87:571-576.
• [10]Kauther MD,Zimmermann C,Bachmann H,et al.Biochemical markersof particle induced osteolysis in C57BL/6 mice[J].Clin Chem LabMed,2010,48:1641-1646.
• [11]Streich NA,Gotterbarm T,Jung M,et al.Biochemical markers of boneturnover in aseptic loosening in hip arthroplasty[J].Int Orthop,2009,33:77-82.
• [12]武文,戴尅戎.人工关节无菌性松动诊断标志物研究进展[J].国际骨科杂志,2009,30:3-6.
• [13]陶良,张先龙,沈灏,等.人工关节松动的药物和基因治疗进展[J].中国矫形外科杂志,2009,17:278-281.
• [14]Wada T,Nakashima T,HiroshiN,et al.RANKL-RANK signaling inosteoclastogenesis and bone disease[J].Trends Mol Med,2006,12:17-25.
• [15]Childs LM,Goater JJ,O’Keefe RJ,et al.Efficacy of etanercept forwear debris-induced osteolysis[J].J Bone Miner Res,2001,16:338-347.
• [16]Arabmotlagh U,Pilz M,Warzecha J,et al.Changes of femoral peripros-thetic bone mineral density6 years after treatment with alendronate fol-lowing total hip arthroplasty[J].J Orthop Res,2009,27:183-188.
• [17]Yang SY,Wu B,Mayton L,et al.Protective effects of IL-I Ra or vlL-10 gene transfer on a murine model of wear debris-induced osteoly-sis[J].Gene Ther,2004,5:483-491.
• [18]Wakita T,Mogi M,Kurita K,et al.Increase in RANKL:OPG ratio insynovia of patients with temporomandibular joint disorder[J].DentRes,2006,85:627-632.
• [19]Ulrich-Vinther U,Carmody EE,Goater JJ,et al.Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibitswear debris-induced osteolysis[J].J Bone Joint Surg Am,2002,84:1405-1412.
• [20]Iqbal J,Sun L,Zaidi U.Denosumab for the treatment of osteoporosis[J].Curr Osteoporos Rep,2010,8:163-167.
• [21]Friedl G,Radl R,Stihsen C,et al.The effect of a single infusion ofzoledronic acid on early implant migration in total hip arthroplasty.Arandomized,double-blind,controlled trial[J].J Bone Joint Surg Am,2009,91:274-281.
• [22]Arabmotlagh M,Pilz M,Warzecha J,et al.Changes of femoral peripros-thetic bone mineral density6 years after treatment with alendronate fol-lowing total hip arthroplasty[J].J Orthop Res,2009,27:183-188.
• [23]Woo SB,Hellstein JW,Kalmar JR.Systemic review:bisphosphonatesand osteonecrosis of the jaws[J].Ann Intern Med,2006,144:753-761.
• [24]Ren W,Wu B,Peng X,et al.Erythromycin inhibits wear debris-in-duced inflammatory osteolysis in a murine model[J].J Orthop Res,2006,24:280-290.
• [25]Zhang C,Tang TT,Ren WP,et al.Inhibiting wear particles-inducedosteolysis with doxycycline[J].Acta Pharmacol Sin,2007,28:1603-1610.